January 7, 2008 - Imaging for early cardiovascular disease that causes heart attack and stroke is the focus of the High-Risk Plaque (HRP) Initiative, a new study to develop improved techniques for identifying individuals at risk for heart attacks and of advanced methods to monitor disease progression and treatment response.

The HRP Initiative, formed by Merck, AstraZeneca, Philips Medical Systems and BG Medicine, has recenlty added HealthHelp to coordinate national and market-specific clinical investigators, create safety processes and review patient images for incidental findings as part of HRP’s BioImage Study.

The BioImage Study aims to recruit approximately 7,300 asymptomatic patients with risk factors for HRP, stroke and heart disease to undergo blood tests and advanced imaging studies including ultrasound, CTs and MRIs. One of the initiative's primary goals is to determine the correlation between imaging and blood biomarkers and three-year heart-attack/stroke rates.

CT, MRI and ultrasound scans will be performed in investigational clinics established by BG Medicine in Chicago, Louisville and Miami. Radiological clinical investigators will oversee patient scanning and safety throughout the study. HealthHelp will also serve as a liaison between BG Medicine and NightHawk Radiology Services, which will be responsible for reading the scans for incidental findings that might affect patients' health.

HealthHelp has recruited the following prominent physicians to serve as clinical investigators for the BioImage Study:

Ebrahim S. Delpassand, M.D., chairman and director of Excel
Diagnostics Imaging Clinics in Houston
James T. Bui, M.D., assistant professor of radiology,
University of Illinois at Chicago
Albert Seow, M.D., professor of radiology, University of
Louisville School of Medicine
Hermes J. Florez, M.D., MPH, Ph.D., assistant professor of
clinical medicine, University of Miami Miller School of Medicine

For more information: www.healthhelp.com


Related Content

Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Time March 07, 2024
arrow
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Time February 20, 2024
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Mobile C-Arms

July 29, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ...

Time July 29, 2022
arrow
News | SCCT

July 8, 2022 — The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document on ...

Time July 08, 2022
arrow
News | PET-CT

January 12, 2022 — By combining information from two advanced imaging techniques with clinical data, physicians can ...

Time January 12, 2022
arrow
Feature | Computed Tomography (CT) | By Dave Fornell, ITN Editor

The U.S. Food and Drug Administration (FDA) cleared the world's first photon-counting computed tomography (CT) scanner ...

Time November 04, 2021
arrow
News | Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

Time October 14, 2021
arrow
News | Artificial Intelligence

September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth U.S ...

Time September 27, 2021
arrow
News | Cardiac Imaging

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by ...

Time September 23, 2021
arrow
Subscribe Now